X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
humans (53) 53
aged (46) 46
female (46) 46
middle aged (46) 46
male (44) 44
hematology (40) 40
article (33) 33
oncology (28) 28
aged, 80 and over (27) 27
rituximab (27) 27
adult (25) 25
cancer (23) 23
treatment outcome (23) 23
prognosis (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
leukemia, lymphocytic, chronic, b-cell - drug therapy (19) 19
chronic lymphocytic leukemia (17) 17
cyclophosphamide (15) 15
abridged index medicus (14) 14
disease-free survival (13) 13
survival (13) 13
therapy (13) 13
cll (12) 12
leukemia, lymphocytic, chronic, b-cell - pathology (12) 12
antineoplastic agents - therapeutic use (11) 11
hemic and lymphatic diseases (11) 11
neoplasm staging (11) 11
survival analysis (10) 10
survival rate (10) 10
alemtuzumab (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
care and treatment (9) 9
follow-up studies (9) 9
hematology, oncology and palliative medicine (9) 9
recurrence (9) 9
research (9) 9
antibodies, monoclonal - therapeutic use (8) 8
chemoimmunotherapy (8) 8
chemotherapy (8) 8
clinical trials and observations (8) 8
everolimus (8) 8
fludarabine (8) 8
thalidomide - analogs & derivatives (8) 8
apoptosis (7) 7
combination (7) 7
diagnosis (7) 7
disease progression (7) 7
drug resistance, neoplasm (7) 7
lenalidomide (7) 7
lymphocyte count (7) 7
multiple myeloma (7) 7
neoplasm recurrence, local - drug therapy (7) 7
trial (7) 7
antibodies, monoclonal, murine-derived (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
b-cells (6) 6
cyclophosphamide - administration & dosage (6) 6
drug administration schedule (6) 6
kaplan-meier estimate (6) 6
leukemia, lymphocytic, chronic, b-cell - immunology (6) 6
leukemia, lymphocytic, chronic, b-cell - mortality (6) 6
lymphomas (6) 6
mammalian target (6) 6
multiple myeloma - drug therapy (6) 6
thalidomide - therapeutic use (6) 6
angiogenesis (5) 5
dexamethasone (5) 5
dexamethasone - therapeutic use (5) 5
elderly-patients (5) 5
flow cytometry (5) 5
guidelines (5) 5
immune system diseases (5) 5
immunotherapy (5) 5
initial therapy (5) 5
lymphoma (5) 5
melphalan (5) 5
pentostatin (5) 5
pentostatin - administration & dosage (5) 5
relapse (5) 5
rituximab - administration & dosage (5) 5
sirolimus - analogs & derivatives (5) 5
transplantation (5) 5
treatment (5) 5
102 (4) 4
activation (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - adverse effects (4) 4
antineoplastic agents - adverse effects (4) 4
b-cell lymphoma (4) 4
bevacizumab (4) 4
bortezomib (4) 4
cells (4) 4
chronic lymphocytic leukaemia (4) 4
cohort studies (4) 4
combined modality therapy (4) 4
dexamethasone - administration & dosage (4) 4
diseases (4) 4
leukemia, lymphocytic, chronic, b-cell - blood (4) 4
leukemia, lymphocytic, chronic, b-cell - genetics (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2811 - 2811
Background: FDG PET/CT and bone marrow biopsy (BMB) are considered standard procedures for the staging of patients with new, untreated FL. A key issue in FL is... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2010, Volume 28, Issue 8, pp. 1408 - 1414
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3, pp. 251 - 257
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2014, Volume 89, Issue 3, pp. 237 - 242
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 07/2018, Volume 8, Issue 7, pp. 63 - 5
Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is a devastating event occurring in similar to 5% of patients treated with... 
STUDY-GROUP DSHNHL | TRIAL | B-CELL LYMPHOMA | NERVOUS-SYSTEM PROPHYLAXIS | RISK-FACTORS | ONCOLOGY | RITUXIMAB | NON-HODGKINS-LYMPHOMA | PHASE-II | AGGRESSIVE LYMPHOMA | HEMATOLOGY | ELDERLY-PATIENTS
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2019, Volume 94, Issue 7, pp. 786 - 793
Predicting early clinical failure in patients with untreated follicular lymphoma (FL) is important but difficult. This study aimed to determine the incidence... 
Medicine, Experimental | Medical research | Pets | Lymphomas | Prognosis | PET imaging
Journal Article
Blood, ISSN 0006-4971, 06/2017, Volume 129, Issue 26, pp. 3419 - 3427
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2012, Volume 91, Issue 1, pp. 33 - 38
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1004 - 1010
Patients with relapsed aggressive non-Hodgkin lymphoma (NHL) are often treated with platinum-based chemoimmunotherapy regimens in preparation for autologous... 
B-CELL LYMPHOMA | ETOPOSIDE | PHASE-II | HIGH-DOSE CYTARABINE | CANDIDATES | HEMATOLOGY | SALVAGE REGIMEN | CHEMOTHERAPY | GEMCITABINE | TRANSPLANTATION | Recombinant Proteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Cytarabine - adverse effects | Recombinant Proteins - adverse effects | Filgrastim | Rituximab - therapeutic use | Organoplatinum Compounds - administration & dosage | Lymphoma, B-Cell - immunology | Female | Lymphoma, B-Cell - drug therapy | Rituximab - adverse effects | Granulocyte Colony-Stimulating Factor - adverse effects | Antigens, CD20 - immunology | Dexamethasone - administration & dosage | Lymphoma, B-Cell - mortality | Drug Administration Schedule | Polyethylene Glycols | Kaplan-Meier Estimate | Drug-Related Side Effects and Adverse Reactions - etiology | Granulocyte Colony-Stimulating Factor - therapeutic use | Cytarabine - administration & dosage | Recombinant Proteins - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rituximab - administration & dosage | Disease-Free Survival | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell - pathology | Aged | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Relapse | Pyrimidines | Dexamethasone | Cytarabine | Oncology, Experimental | Stem cells | Research | Cancer | Diseases | Steroids | Index Medicus
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4139 - 4139
Abstract Introduction. The peripheral blood absolute lymphocyte (ALC)/monocyte (AMC) ratio (ALC/AMC), as a surrogate of host immunity (i.e. ALC) and tumor... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2017, Volume 92, Issue 8, pp. 759 - 763
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2014, Volume 89, Issue 7, pp. 757 - 765
Journal Article